These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


87 related items for PubMed ID: 24670360

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Primary hyperparathyroidism with a low-normal, atypical serum parathyroid hormone as shown by discordant immunoassay curves.
    Lafferty FW, Hamlin CR, Corrado KR, Arnold A, Shuck JM.
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3826-9. PubMed ID: 16849415
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Novel electrochemiluminescence immunoassay exclusively for full-length parathyroid hormone during treatment with cinacalcet for secondary hyperparathyroidism.
    Tanaka H, Komaba H, Koizumi M, Kakuta T, Fukagawa M.
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():56-61. PubMed ID: 21595854
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
    Bhadada SK, Cardenas M, Bhansali A, Mittal BR, Behera A, Chanukya GV, Nahar U, Rao DS.
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W.
    Wien Klin Wochenschr Suppl; 1975 Sep; 33():1-15. PubMed ID: 176830
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The role of quick bio-intact PTH(1-84) assay during parathyroidectomy for secondary hyperparathyroidism.
    Ikeda Y, Kurihara H, Morita N, Miyabe R, Takami H.
    J Surg Res; 2007 Aug; 141(2):306-10. PubMed ID: 17418873
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.
    Nakanishi S, Kazama JJ, Nii-Kono T, Omori K, Yamashita T, Fukumoto S, Gejyo F, Shigematsu T, Fukagawa M.
    Kidney Int; 2005 Mar; 67(3):1171-8. PubMed ID: 15698459
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.